Your browser doesn't support javascript.
loading
SMUG1 regulates fat homeostasis leading to a fatty liver phenotype in mice.
Carracedo, Sergio; Lirussi, Lisa; Alsøe, Lene; Segers, Filip; Wang, Changliang; Bartosova, Zdenka; Bohov, Pavol; Tekin, Nuriye B; Kong, Xiang Yi; Esbensen, Q Ying; Chen, Liang; Wennerström, Anna; Kroustallaki, Penelope; Ceolotto, Deborah; Tönjes, Anke; Berge, Rolf Kristian; Bruheim, Per; Wong, Garry; Böttcher, Yvonne; Halvorsen, Bente; Nilsen, Hilde.
Afiliação
  • Carracedo S; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Lirussi L; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Alsøe L; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Segers F; Research Institute of Internal Medicine, Oslo University Hospital, Institute of Clinical Medicine, N-0318 Oslo, Norway.
  • Wang C; Cancer Centre, Centre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Taipa, Macao Special Administrative Region of China.
  • Bartosova Z; Department of Biotechnology and Food Science, Faculty of Natural Sciences, NTNU Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
  • Bohov P; Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway.
  • Tekin NB; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Kong XY; Research Institute of Internal Medicine, Oslo University Hospital, Institute of Clinical Medicine, N-0318 Oslo, Norway.
  • Esbensen QY; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Chen L; Cancer Centre, Centre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Taipa, Macao Special Administrative Region of China; Department of Computer Science, College of Engineering, Shantou University, Shantou 515063, China.
  • Wennerström A; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway.
  • Kroustallaki P; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Ceolotto D; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway.
  • Tönjes A; Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04109 Leipzig, Germany.
  • Berge RK; Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway.
  • Bruheim P; Department of Biotechnology and Food Science, Faculty of Natural Sciences, NTNU Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
  • Wong G; Cancer Centre, Centre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Taipa, Macao Special Administrative Region of China.
  • Böttcher Y; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway.
  • Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Institute of Clinical Medicine, N-0318 Oslo, Norway.
  • Nilsen H; Section of Clinical Molecular Biology, Akershus University Hospital, N-1474 Nordbyhagen, Norway; Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo, N-0318 Oslo, Norway; Department of Microbiology, Oslo University Hospital, N-0424 Oslo, Norway. Electronic ad
DNA Repair (Amst) ; 120: 103410, 2022 12.
Article em En | MEDLINE | ID: mdl-36244177
ABSTRACT
Fatty liver diseases are a major health threat across the western world, leading to cirrhosis and premature morbidity and mortality. Recently, a correlation between the base excision repair enzyme SMUG1 and metabolic homeostasis was identified. As the molecular mechanisms remain unknown, we exploited a SMUG1-knockout mouse model to gain insights into this association by characterizing the liver phenotype in young vs old SMUG1-null mice. We observed increased weight and fat content in one-year old animals, with altered activity of enzymes important for fatty acids influx and uptake. Consistently, lipidomic profiling showed accumulation of free fatty acids and triglycerides in SMUG1-null livers. Old SMUG1-knockout mice also displayed increased hepatocyte senescence and DNA damage at telomeres. Interestingly, RNA sequencing revealed widespread changes in the expression of lipid metabolic genes already in three months old animals. In summary, SMUG1 modulates fat metabolism favouring net lipogenesis and resulting in development of a fatty liver phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uracila-DNA Glicosidase / Fígado Gorduroso Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uracila-DNA Glicosidase / Fígado Gorduroso Idioma: En Ano de publicação: 2022 Tipo de documento: Article